We have launched a new ‘Lunch and Learn’ CPD for vets and RVNs, interested in learning more about canine osteoarthritis, which affects up to 20% of all dogs in the UK annually1.
The session will help veterinary staff learn more about the condition; the causes and consequences of osteoarthritis pain, the main predisposing risk factors, as well as the impact of chronic pain on central sensitisation.
This CPD will look at what steps practices can take to mitigate animal suffering and increase long-term owner compliance and will encourage practices to look at their current osteoarthritis management strategy and encourage changes where necessary.
Kai Crawshaw, Brand Manager at Animalcare, said:
‘Canine osteoarthritis is a growing concern for UK vets – latest figures suggest that over two million dogs are suffering, based on current population figures.
‘Managing these cases can be challenging, but through this lunch and learn session, we aim to support veterinary staff and help them to expand their knowledge and implement an improved approach for managing canine osteoarthritis.’
Animalcare is the distributor of Daxocox®, the first and only weekly oral NSAID, which is designed for consistent osteoarthritis pain and inflammation management and provides effective pain relief in all disease stages.
1.Anderson, K.L., O’Neill, D.G., Brodbelt, D.C., et al, 2018. Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care. Scientific reports, 8(1), pp.1-12.